Worth reading
26Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Incoming appointee
2 itemsScheduled Appointment Date22 June 2026 (scheduled to be formally decided at the annual general meeting of キョーリン製薬グループ工場株式会社)
Fukuda Mamoru (福田 守)
Previous positionGeneral Manager, Production Operations Division
New positionDirectors
Hamada Katsuhiro (濱田 佳津宏)
Previous positionNot disclosed
New positionStatutory Auditors
Departing officer
2 itemsDate of departure22 June 2026
Onoda Michiro (大野田 道郎)Next role stated
Former PositionChairman of the Board
New positionRetirement
Matsumoto Tomoharu (松本 臣春)Next role stated
Former PositionStatutory Auditors
New positionRetirement
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
Will not remain on the Board of Directors
Shareholders’ meeting approvalFormal decision at the annual general meeting of キョーリン製薬グループ工場株式会社 scheduled for 22 June 2026
| Item | Details |
|---|---|
| Scheduled Appointment Date | 22 June 2026 (scheduled to be formally decided at the annual general meeting of キョーリン製薬グループ工場株式会社) |
| Date of departure | 22 June 2026 |
| Name of appointee | Fukuda Mamoru (福田 守), Hamada Katsuhiro (濱田 佳津宏) |
| Appointee's new position | Directors, Statutory Auditors |
| Appointee's previous position | General Manager, Production Operations Division, Not disclosed |
| Name of departing officer | Onoda Michiro (大野田 道郎), Matsumoto Tomoharu (松本 臣春) |
| Former position of departing officer | Chairman of the Board, Statutory Auditors |
| New position of departing officer | Retirement, Retirement |
| Whether the incumbent will remain in office | Will not remain on the Board of Directors |
| Subject to Approval by the General Meeting of Shareholders | Formal decision at the annual general meeting of キョーリン製薬グループ工場株式会社 scheduled for 22 June 2026 |
Items this document does not state (11)
Resolution dateAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for departureReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No reason for the changes is provided.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.